RFMH bridges New York State's mental hygiene agencies—OMH, OPWDD, OASAS—with federal and foundation research sponsors, managing sponsored research programs across three state institutes. The project portfolio spans neurodevelopmental genetics, in vivo neural imaging, substance-use outcomes tracking, and implementation science, backed by a research-heavy hiring mix (15 of 32 active roles) focused on closing treatment-access and outcome-disparity gaps. Pain-point clustering around audit readiness and policy compliance signals a compliance-and-operations-focused organization scaling administrative capacity.
Notable leadership hires: Operations Assistant Director
RFMH is a 1952-founded nonprofit chartered to administer sponsored research for New York State's Department of Mental Hygiene. The foundation serves as the administrative vehicle through which scientists at state mental-health, developmental-disability, and substance-abuse institutes access federal, state, and foundation funding. RFMH provides contract administration, regulatory oversight (IRB reliance, HRPP policy), technology transfer, and operational independence—functions historically difficult within state bureaucracy. Current research activity spans neurobiology (mouse models, calcium imaging), policy work (substance-use outcomes, legislation commentary), and service-implementation programs (IPS training, court-reach initiatives). The organization operates across three research institutes plus central offices in Menands, New York.
RFMH administers all sponsored research for NY's Office of Mental Health, Office for People with Developmental Disabilities, and Office of Alcoholism and Substance Abuse Services. It acts as the contracting and compliance intermediary between state scientists and federal, state, and foundation sponsors.
Projects include neurodevelopmental genetics in mouse models, in vivo neural imaging, substance-use treatment outcomes tracking, IPS implementation training, and policy development around alcohol and drug services. Pain points center on reducing treatment disparities and increasing access to evidence-based care.
Other companies in the same industry, closest in size